ANDA 62494, held by Superpharm. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62494 (Doxycycline Hyclate), held by Superpharm, was first approved by FDA on Feb 20, 1985, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 20, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxycycline HyclateEQ 100MG BASE ยท tablet;oral | Doxycycline Hyclate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters